HB1013
To Protect Fertility Treatment Rights In This State.
AI-Generated Summary
House Bill 1013, titled the "Act To Protect Fertility Treatment Rights In This State," seeks to establish a statutory right for individuals to receive and continue fertility treatments in Arkansas. The bill defines various aspects of fertility treatment, including preservation of reproductive materials, assisted reproductive technology, and genetic testing of embryos, based on widely accepted and evidence-based medical standards of care, specifically referencing guidelines from the American Society for Reproductive Medicine. It explicitly grants rights to individuals to receive such treatment, make decisions regarding their reproductive genetic material, and enter into agreements with providers. Concurrently, the bill grants corresponding rights to healthcare providers to offer these treatments according to the established standards of care. It also protects healthcare insurers' right to cover these treatments and manufacturers' right to supply necessary drugs and devices. The legislation includes enforcement provisions allowing civil actions against entities that impede these rights, with prevailing plaintiffs eligible for the recovery of litigation costs and attorney's fees.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries of this bill are individuals in Arkansas seeking fertility treatments, as it enshrines their right to receive, continue, and make decisions regarding fertility services and their reproductive genetic material, provided these services adhere to widely accepted and evidence-based medical standards of care. Healthcare providers who offer fertility treatments will benefit from explicit statutory protection ensuring they can practice according to these recognized medical standards without undue prohibition or interference. Furthermore, healthcare insurers who choose to cover these services and manufacturers who produce the related drugs and devices will have their rights to operate and market within the scope of these defined treatments legally protected under Arkansas code.
Who Might Suffer?
Entities that could be negatively impacted are state or local government bodies, officials, or agencies whose existing laws or regulations may restrict, limit, or impede the fertility treatments defined in the bill, as they may face civil enforcement actions for enacting or enforcing such limitations. Healthcare providers or facilities whose established medical practices fall outside the bill's definition of "widely accepted and evidence-based medical standards of care" (i.e., ASRM guidelines) might face conflicting mandates or risks associated with adherence to the new law. Additionally, healthcare insurers who do not wish to cover fertility treatments may find their operational flexibility curtailed if existing contractual or regulatory requirements are superseded by this bill's protections, although the bill seems to protect the right to cover rather than mandate coverage.